Ordering
Available Variants10 mL
CHA.23178-10mL
Price
€60.08
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mL | CHA.23178-10mL | €60.08 |
Ready Made Solution, 25 mg/mL in water
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| CAS Number | 149022-22-0 |
|---|---|
| NACRES | NA.76 |
| UNSPSC Code | 51281632 |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H317 |
| pcodes | P261 - P272 - P280 - P302 + P352 - P333 + P313 - P362 + P364 |
| Hazard Classifications | Skin Sens. 1 |
| Storage Class | 12 - Non Combustible Liquids |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Amikacin, with the chemical formula C22H43N5O13 and CAS number 149022-22-0, is an aminoglycoside antibiotic used to treat various bacterial infections. It functions by inhibiting protein synthesis in bacteria, ultimately leading to their death. Amikacin is particularly effective against gram-negative bacteria, including those resistant to other antibiotics such as gentamicin and tobramycin. Its mechanism of action involves binding to the 30S subunit of the bacterial ribosome, which disrupts the initiation complex of peptide formation and causes misreading of mRNA. Amikacin is administered parenterally, typically via intramuscular or intravenous injection, and its dosage is carefully monitored due to the potential for nephrotoxicity and ototoxicity. As with other aminoglycosides, amikacins use is reserved for serious infections where its benefits outweigh the risks associated with its administration.
